e-learning
resources
Virtual 2020
Pre-Congress Content
Advances in asthma treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process
J. Upham (Brisbane , Australia), C. Le Lievre (Singapore, Singapore), D. Jackson (London, United Kingdom), M. Masoli (Plymouth, United Kingdom), M. Wechsler (Denver, United States of America), D. Price (Singapore, Singapore)
Source:
Virtual Congress 2020 – Advances in asthma treatment
Session:
Advances in asthma treatment
Session type:
E-poster session
Number:
2610
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Upham (Brisbane , Australia), C. Le Lievre (Singapore, Singapore), D. Jackson (London, United Kingdom), M. Masoli (Plymouth, United Kingdom), M. Wechsler (Denver, United States of America), D. Price (Singapore, Singapore). Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process. 2610
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Late Breaking Abstract - A symptom-based algorithm to improve asthma diagnosis in early childhood:the CHILD Cohort Study
Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics
Year: 2019
Late Breaking Abstract - Development of a self-management package for pulmonary fibrosis: an international Delphi study
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Year: 2021
Late Breaking Abstract - Lung involvement is clue for recognizing severe dengue-A retrospective study
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2
Year: 2020
Late Breaking Abstract - iPREDICT: Pilot study to develop predictive model of changes in asthma control
Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Year: 2019
Late Breaking Abstract - Automated coaching for physical activity in COPD patients: results from a pilot study
Source: International Congress 2017 – Innovation in pulmonary rehabilitation and chronic care
Year: 2017
Late Breaking Abstract - Implications of new PH definition for CTEPD
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021
Late Breaking Abstract - Pharmacological and clinical management of severe asthma in 9 countries: An international survey of clinicians.
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Late Breaking Abstract - COPD patient´s adherence to pulmonary rehabilitation programs: scoping review
Source: Virtual Congress 2021 – Pulmonary rehabilitation in asthma and COPD
Year: 2021
Late Breaking Abstract - Longitudinal analysis of variation in clinical features from the U-BIOPRED severe asthma cohort
Source: International Congress 2018 – Notable Studies in Asthma
Year: 2018
Late Breaking Abstract - Cluster analysis of treatable traits in the U-BIOPRED adult severe asthma cohort
Source: International Congress 2017 – Asthma and ACOS: predictors and clinical characteristics
Year: 2017
Late Breaking Abstract - Second Souffle: preliminary results from a national survey on the care pathways and quality of life of patients with T2 severe asthma
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019
Late Breaking Abstract - Childhood farming environment: Association to age at asthma diagnosis in a population-based study
Source: Virtual Congress 2021 – New evidence from longitudinal asthma cohorts and other key studies
Year: 2021
Late Breaking Abstract - Reimbursement for asthma care is a universal barrier to achieving asthma symptom control: the SABINA III study
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020
Late Breaking Abstract - Asthma control in preschool and subsequent disease remission
Source: International Congress 2019 – Asthma and the world
Year: 2019
Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Late Breaking Abstract - Geographic accessibility and chronic respiratory disease outcomes: a decision support tool
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019
Late Breaking Abstract - The humanistic burden of asthma patients uncontrolled on ICS-LABA: a systematic literature review
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Late Breaking Abstract - Effects of pulmonary rehabilitation on major symptoms of long COVID (post-COVID-19 syndrome): preliminary results
Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases
Year: 2021
Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept